These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22548530)
1. Gutter method: noninvasive management of ingrown nails caused by epidermal growth factor inhibitor treatment. Harada K; Yamaguchi M; Miyajima S; Kawamura T; Shibagaki S; Shimada S Clin Exp Dermatol; 2012 Aug; 37(6):703-4. PubMed ID: 22548530 [No Abstract] [Full Text] [Related]
2. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor. Eames T; Landthaler M; Karrer S Eur J Dermatol; 2007; 17(6):552-3. PubMed ID: 17951151 [No Abstract] [Full Text] [Related]
3. Successful treatment of pyogenic granulomas following gefitinib therapy with partial matricectomy and phenolization. Dika E; Balestri R; Vaccari S; Alessandro Fanti P; Misciali C; Patrizi A J Dermatolog Treat; 2009; 20(6):374-5. PubMed ID: 19954397 [No Abstract] [Full Text] [Related]
4. Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer. Koutras AK; Mastronikolis NS; Evans TR; Papadeas ES; Makatsoris T; Kalofonos HP Acta Oncol; 2008; 47(6):1171-3. PubMed ID: 18615326 [No Abstract] [Full Text] [Related]
5. A simple and practical method in treatment of ingrown nails: splinting by flexible tube. Nazari S J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1302-6. PubMed ID: 17062049 [TBL] [Abstract][Full Text] [Related]
6. Erlotinib-induced trichomegaly in a male patient with pancreatic cancer. Saif MW; Gnanaraj J Cutan Ocul Toxicol; 2010 Mar; 29(1):62-6. PubMed ID: 19954400 [TBL] [Abstract][Full Text] [Related]
7. Phenol 8% solution for the treatment of epidermal growth factor receptor inhibitor-induced periungual pyogenic granulomas. Panariello L; Caro G; Bianca D; Fabbrocini G G Ital Dermatol Venereol; 2015 Dec; 150(6):755-6. PubMed ID: 26513046 [No Abstract] [Full Text] [Related]
8. Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva). Lübbe J; Masouyé I; Dietrich PY Dermatology; 2008; 216(3):247-9. PubMed ID: 18182820 [TBL] [Abstract][Full Text] [Related]
9. Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib. Vergou T; Stratigos AJ; Karapanagiotou EM; Matekovits AE; Dilana KD; Tsimboukis S; Antoniou C; Chasapi V; Syrigos KN J Am Acad Dermatol; 2010 Aug; 63(2):e56-8. PubMed ID: 20633793 [No Abstract] [Full Text] [Related]